Non-enzymatic debriding agent and method of use thereof

Inventors

Sanders, Mitchell

Assignees

Alira Health Boston LLC

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12403108-B2

Patent

Publication Date

2025-09-02

Expiration Date


Abstract

A non-enzymatic debridement agent that is less expensive, less cytotoxic, and more effective than enzymatic and sharp surgical debridement of eschar material. The non-enzymatic debridement agent is based on a formulation of detergent with a high critical micelle concentration and a denaturing agent along with an optional optimized buffer. The non-enzymatic wound debriding agent is able to dissolve eschar material in under one week. The buffer or ointment may contain an optimized pH, salt concentration, reducing agent, and other components that aid in the debridement of eschar material from chronic wounds and burn wounds. The non-enzymatic debridement agent can be formulated as an ointment, liquid rinse under pressure, and/or as a combination product with an advanced wound dressing that can act as a sink to remove the solubilized eschar material from the surface of the wound to assist in the debridment and proper healing of wounds.

Core Innovation

The invention provides a non-enzymatic wound debriding agent for application to necrotic human tissue that includes eschar that develops slough. The agent is formulated to act on necrotic material without enzymes, and is characterized by a micelle formulation containing urea in a concentration of 100-500 mM. The formulation further includes a gentle detergent with a high critical micelle concentration (CMC) of greater than 19 mM, and the micelles have hydrophilic denaturing cores that include the urea.

The described agent additionally includes sodium chloride, a physiological buffer, and water. In dependent aspects, the detergent headgroups are defined using glycosidic headgroups of alkyl β-glucosides and/or alkyl β-maltosides with alkyl chain lengths between 8 and 14, or as peptide-based peptergent and HECAMEG, while maintaining the gentle, high-CMC micelle behavior. Further dependent aspects define buffer compositions using ACES, PBS, and/or MES, and specify the agent in solution formats or in gel or ointment formats.

The invention also provides a method of debriding a wound by applying the non-enzymatic wound debriding agent with the urea-containing, high-CMC detergent micelle formulation to the wound. The method coverage includes application of the micelle formulation comprising 100-500 mM urea, sodium chloride, a physiological buffer, and water. Dependent aspects refine delivery and composition, including gel or ointment forms and optional inclusion of peptide or peptide-like non-mercaptan reducing agents.

Claims Coverage

The document includes two independent claims: one directed to a non-enzymatic wound debriding agent composition and one directed to a method of debriding a wound by applying the composition. Across the independent claims, the main inventive features are the urea-containing micelle formulation, the use of a gentle detergent with a high critical micelle concentration (CMC) producing hydrophilic denaturing micelle cores that include urea, and the formulation context comprising sodium chloride, a physiological buffer, and water.

Urea-containing hydrophilic denaturing micelle formulation in a gentle high-CMC detergent

A non-enzymatic wound debriding agent comprising 100-500 mM urea and a gentle detergent with a high critical micelle concentration (CMC) greater than 19 mM, wherein micelles have hydrophilic denaturing cores that include the urea.

Physiological salt and buffer formulation context for the micelle system

The non-enzymatic wound debriding agent additionally comprises sodium chloride, a physiological buffer, and water.

Applying the non-enzymatic micelle-formulated urea detergent composition to a wound

A method of debriding a wound comprising applying to the wound a non-enzymatic wound debriding agent that comprises a micelle formulation comprising 100-500 mM urea and a gentle detergent with a high critical micelle concentration (CMC) greater than 19 mM, wherein the micelles have hydrophilic denaturing cores that include the urea.

Method composition includes sodium chloride, physiological buffer, and water

In the debriding method, the applied non-enzymatic wound debriding agent further comprises sodium chloride, a physiological buffer, and water.

The claim set centers on a non-enzymatic wound debriding composition defined by a urea (100-500 mM) micelle system using a gentle detergent with a high CMC (>19 mM) that yields hydrophilic denaturing micelle cores containing urea, together with sodium chloride, a physiological buffer, and water, and on applying that composition to debride necrotic wounds.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.